Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Joe DiMaggio Children’s Hospital Pediatric Heart Transplant Program Celebrates a Milestone


News Image

“The most rewarding part for our work is being able to take a child and a family that is so encumbered by that child’s illness and carry them from a state of grief and uncertainty to a child’s state of wellness and the family’s state of joy and hope for the future.” – Dr. Maryanne Chrisant

For every program created at Joe DiMaggio Children’s Hospital, there is a purpose, a vital service to offer and most importantly, the collective commitment to saving lives. Ten years ago, the Pediatric Heart Transplant Program at Joe DiMaggio Children’s Hospital received its certification from UNOS (United Network for Organ Sharing) and the program’s impact on South Florida and beyond has been accomplished one heartbeat at a time.

As the team of cardiac experts, who were recruited from across the country, honor the program’s decade milestone, the true celebration is focused on the many lives saved and the families they have kept together throughout the unique journey of heart transplantation. To date, the transplant team at Joe DiMaggio Children’s Hospital Heart Institute have performed 67 pediatric heart transplants with many more children on the list awaiting the gift of life.

“Most of our patients have come from and around the tri-county area, and southwest Florida. Others have come from cities all over the state,” said Dr. Frank Scholl, Chief of the Joe DiMaggio Children’s Hospital Heart Institute, who performed the first heart transplant in the hospital’s history 10 years ago.

The data from the program shows that patients have done amazingly well, even beyond the critical three-year survival rate post-transplant.

“In the past year, we’ve had two-24-hour days where we’ve done two transplants. It shows our level of where our team has gotten to – to be able to accomplish that and make it routine,” Scholl adds.

The cardiac transplant program at Joe DiMaggio’s Children Hospital Heart Institute has expanded in the last decade. It now offers wraparound services in support of heart transplant patients, and the team’s expertise spans across multiple disciplines, including congenital heart care, cardiomyopathy, advanced heart failure, critical care, and mechanical circulatory support. To date, more than thirty patients have been supported with mechanical circulatory support using ventricular assisted devices including the Berlin Heart Excor, Heartware HVAD, Pedimag and Impella devices. Caring for these patients is complex and requires a highly specialized team to monitor and maintain these patients in a state of readiness for transplant, recovery, or another cardiac intervention.

In addition to the medical expertise and the compassionate care provided by a supporting team of nurses and other specialists, the donor families are vital to each patient’s journey. “We are ever grateful to all our donor families, who in their deepest grief were thinking of others. They are the ones who make it possible for our patients to have a second chance,” said Dr. Maryanne Chrisant, Medical Director, Pediatric Cardiac Transplant, Heart Failure and Cardiomyopathy. She was recruited to Joe DiMaggio Children’s Hospital more than a decade ago to help build the cardiac transplant and related programs. “Our clinical expertise and excellent outcomes have earned the Joe DiMaggio Children’s Hospital heart transplant program national and international recognition.”

As the team reflects on such a historical milestone for the program, Dr. Chrisant says, “The most rewarding part for our work is being able to take a child and a family that is so encumbered by that child’s illness and carry them from a state of grief and uncertainty to a child’s state of wellness and the family’s state of joy and hope for the future.”

Dr. Scholl adds his insights from the past decade: “The program was started so people could have world class pediatric heart care in their own backyard. Now that has been reversed, and we are caring for patients that are coming from hundreds and thousands of miles away – out of the country even, to have their heart care here. And that’s really the mark of what we’ve done and shows the reputation we’ve built.”

HEART SMARTS


  • 10 years – Pediatric Heart Transplant program launched on Dec. 10, 2010.
  • 67 patients – Performed 67 heart transplants.
  • 2 times 2 – Performed two heart transplants in one 24-hour period — a rare and incredibly special occurrence – and the team did it twice, once in June and again in October!
  • 100% survival- Joe DiMaggio Children’s Hospital Heart Institute is proud of its 1 and 3-year survival rate.
  • 1 of 4 – One of only four children’s heart transplant programs in Florida.
  • 1st – Performed the first children’s implant of a HeartWare biventricular assist device in South Florida. The patient was sent home!
  • 11 counties – Families have come from 11 Florida counties for their children’s heart transplants.
  • U.S. News Badge – Joe DiMaggio Children’s Hospital is ranked among the Best Children’s Hospitals for Cardiology & Heart Surgery, by U.S. News & World Report.

As Joe DiMaggio Children’s hospital looks to the future and continued growth of its nationally recognized facility, the need for additional space is vital. A currently underway expansion project will double the floors of the current hospital building to eight. It will feature an expansion of 156,000 square feet, including floors/areas dedicated to the following:

  • Heart Institute, including a Cardiovascular Intensive Care Unit (CVICU)
  • Cardiac procedure rooms
  • Post-anesthesia cardiac unit
  • Medical/Surgical
  • Rehabilitation unit with gym
  • Intensive Care Unit
  • Intermediate care
  • Spaces for patients and families

For more information about the Joe DiMaggio Children’s Hospital Heart Institute, please call 954-265-3437 or visit online.

Joe DiMaggio Children’s Hospital is one of South Florida’s leading pediatric hospitals, offering a comprehensive scope of healthcare services and programs in a caring, compassionate setting designed specifically for children. Part of the Memorial Healthcare System, the level one pediatric trauma center combines advanced technology, the expertise of some of the region’s most diverse, board-certified specialists, and a patient and family-centered focus to heal the body, mind, and spirit of those it touches.

To learn more, visit http://www.jdch.com and connect with @jdchospital on Facebook, Twitter, YouTube and Instagram.

Share article on social media or email:

Confluent Health Announces Continued Growth with Xcel Sports Medicine


Greg Mackenzie, Xcel Sports Medicine Owner and Physical Therapist

Our patients are our neighbors, and we aim to provide best-in-class care through streamlining clinic capabilities, keeping our PTs at the forefront of our field through educational opportunities, and always exceeding expectations.

Confluent Health is proud to announce their newest partnership with Xcel Sports Medicine, a privately owned physical therapy practice with 3 clinic locations across greater Dayton, Ohio.

“At Xcel Sports Medicine our team is dedicated to our patients and delivering personalized care,” says Owner and Physical Therapist, Greg Mackenzie, PT. “Our patients are our neighbors, and we aim to provide best-in-class care through streamlining clinic capabilities, keeping our PTs at the forefront of our field through educational opportunities, and always exceeding expectations. Maintaining the highest standard of care was important when forging this partnership with Confluent Health, and we are excited to join the family.”

This partnership allows Xcel to maintain its existing brand while gaining access to Confluent Health’s shared management services. These services include accounting and finance, marketing and branding, and talent acquisition for further expansion. Through Confluent Health, Xcel therapists will also have greater access to continuing education programs and staff development opportunities such as Evidence In Motion, a nationally recognized physical therapy program.

“Greg has practiced physical therapy in over 15 countries, beginning in his small South African hometown and spanning into New Zealand, Japan and Dubai just to name a few,” says Confluent Health President and CEO Larry Benz, PT, DPT, OCS, MBA, MAPP. “His travels in combination with his expertise in orthopedic, manual and sports physical therapy brings a breath of fresh air to both the PT community and Confluent Health family. We’re thrilled to bring his team’s global approach to patient care to the Confluent family.”

Combining Xcel’s hands-on approach to patient-care with Confluent Health’s shared services footprint will make for a strong partnership and positive impact in the Dayton, Ohio community. For more information on Xcel Physical Therapy, please visit http://www.XcelSportsMedicine.com. To learn more about Confluent Health, visit http://www.GoConfluent.com.

###

About Confluent Health:

Confluent Health is a Louisville, Kentucky-based private holding company focused on creating a healthcare system that recognizes physical and occupational therapy providers as the Best First Choice for preventing and managing musculoskeletal and movement disorders. Confluent Health offers the following management services: evidence-based practice, patient loyalty, regulatory assurance, marketing and branding, clinic operations, hiring and retention, strategy, accounting and finance, and customer service to Advanced and Preferred Physical Therapy, Baton Rouge Physical Therapy-Lake, BreakThrough Physical Therapy, Colorado in Motion, Capitol Physical Therapy, Confluent Physical Therapy, El Paso Physical Therapy Specialists, HPRC, Mountain River Physical Therapy, OSPT, PTPN, the Evidence In Motion family of companies, Fit For Work, Lake Center for Rehab, Rehab Therapy Works, Physical Therapy Central, ProActive Physical Therapy Specialists, Pappas | OPT Physical Therapy, ProRehab Physical Therapy, Redbud Physical Therapy, RET Physical Therapy Group, SporTherapy, Texas Physical Therapy Specialists, TOSPT and Western Berks Physical Therapy and Wellness Center. Together, these companies share a common ownership team and are committed to developing a learning, purpose, and coaching culture.

About Xcel Physical Therapy:

Xcel Sports Medicine is a privately owned and operated, physical therapy practice dedicated to the treatment of athletic and orthopedic injuries. Xcel’s primary aim is to assist with tissue repair and therapeutic activities that accompany it. Xcel has three clinics in the Greater Dayton, Ohio and northern Miami valley area, in Vandalia, Anna and Beavercreek. Xcel’s goal is to restore all patients to their optimal state in the shortest time possible as well as to prevent a recurrence of the issue(s) that brought the patient to them in the first place.

Share article on social media or email:

Promises Behavioral Health Welcomes Brian Stoesz as Vice President of Operations Development


Promises Behavioral Health Welcomes Brian Stoesz as Vice President of Operations Development

In my role as Vice President of Operations Development, I want to bring my thoughtful leadership to Promises and help this organization build an incredible portfolio of innovative, high-quality behavioral health treatment centers.

Promises Behavioral Health, a leader in the behavioral health field, announced the addition of Brian Stoesz as its Vice President of Operations Development. With over 35 years of professional experience, Brian Stoesz is a leader in target acquisitions that promote organizational growth. He also has expertise in laying the foundational groundwork for targeted growth opportunities and has a keen eye for establishing leadership roles within those new markets.

After working through his own addiction challenges over 35 years ago, Brian chose a path with which many in the recovery community are familiar. With the drive to make a difference in the lives of people struggling with substance use disorders, Brian decided to pursue both his undergraduate and master’s degrees in leadership and psychology at Duquesne University. During his time as a counselor in residential addiction rehabilitation, Brian found that he had a passion for helping people find healing and had a clear understanding of how to help treatment centers on a larger scale through his leadership and administration skills. Brian went on to work in a variety of leadership roles, citing his time at Summit Behavioral Health as his most recent career accomplishment. During his time with Summit, Brian was able to significantly grow Summit’s organizational portfolio to aid its reach and ability to help more people.

As the Vice President of Operations Development with Promises Behavioral Health, Brian will utilize this experience to identify specific locations for future growth opportunities, research the marketplaces within those locations and work to build a solid foundation for each new facility. He will also help ascertain quality leadership for these facilities after the initial establishment period and aid in transitioning operations over to the future market CEOs. Brian hopes that within this role, he can help grow the Promises family in a way that is not only thoughtful but also swift and meaningful.

“My experience within the behavioral health field materialized from my own addiction and my passion to make a difference in the lives of people who still suffer,” said Brian. “In my role as Vice President of Operations Development, I want to bring my thoughtful leadership to Promises and help this organization build an incredible portfolio of innovative, high-quality behavioral health treatment centers.”

With Brian playing a large role in these operational efforts, Promises Behavioral Health is stepping into 2021 with a growth mindset and market strategy that will push the organization closer to becoming a national standard in behavioral health care. Along with national recovery communities, the mental health and addiction population can look forward to these support efforts as Promises Behavioral works to ensure individuals can get access to the help they need, no matter where they are in the United States.

About Promises Behavioral Health

Promises Behavioral Health is a family of behavioral health programs with regional brands such as The Right Step, The Ranch and Promises. The company currently operates facilities across Texas, Tennessee, Florida, Pennsylvania and Massachusetts. Promises offers comprehensive, innovative treatment for substance abuse, sexual addiction, trauma, eating disorders and other mental health disorders. Through its programs, the company is committed to delivering clinically sophisticated treatment that promotes permanent lifestyle change, not only for the patient but for the entire family network. For more information, please visit http://www.PromisesBehavioralHealth.com.

Share article on social media or email:

Large-Scale Clinical Study Validates Biospectal’s OptiBP™ Generates Blood Pressure Measurements Equivalent to the Traditional Blood Pressure Cuff


Biospectal OptiBP™ smartphone app provides clinical-grade blood pressure measurement utilizing transdermal optical sensing with only a fingertip applied to a smartphone camera lens

The traditional blood pressure cuff design hasn’t changed in 100+ years. Biospectal’s OptiBP technology will empower patients with a medical-grade device that is integrated into the smartphone already in their pocket and in their natural environment.

Biospectal, the remote patient monitoring and biosensing software company, today announced the publication of the first, large-scale, third-party clinical research study published by Scientific Reports in Nature, which validates the ability of Biospectal’s OptiBP™ smartphone app to accurately measure blood pressure utilizing transdermal optical sensing with only a fingertip applied to a smartphone camera lens. The study, conducted in the hypertensive unit of the CHUV hospital at the University Lausanne in Switzerland, showed reference data captured simultaneously with a phone recording blood flow via a smartphone camera on the patient fingertip.

Biospectal trained its software algorithm utilizing over two million resulting invasively acquired blood pressure samples recorded in the operating room of the CHUV in partnership with the Swiss Center for Electronics and Microtechnology (CSEM), and then validated it with outpatients in the hypertension clinic CHUV. Results revealed Biospectal’s new cuffless, non-invasive optical approach to blood pressure measurement achieved performance equivalent to that of a traditional blood pressure cuff. Biospectal’s OptiBP patented technology was co-developed and also clinically validated by the Swiss Center for Electronics and Microtechnology (CSEM) as well as leading hospitals across multiple countries.

“The clinical study of Biospectal OptiBP published by Scientific Reports in Nature represents the first rigorous, scientifically-validated work that demonstrates the impending medical revolution by putting clinical monitoring in the hands of patients wherever they might happen to be,” said Dr. Patrick Schoettker, MD, Chief Medical Advisor of Biospectal. “The traditional blood pressure cuff design hasn’t changed in 100+ years. Biospectal’s OptiBP technology will empower patients with a medical-grade device that is integrated into the smartphone already in their pocket and in their natural environment, which is ideally where blood pressure should be monitored. OptiBP is an example of a broader transition toward remote patient monitoring that moves the clinical functions and capability out of the professional setting to the ‘point of patient’ where they live.”

How Biospectal OptiBP Works.

The Biospectal OptiBP app runs on a typical smartphone and uses the built-in camera to record and measure a user’s blood flow via their fingertip quickly and easily. Biospectal’s proprietary algorithms and optical signal capture methods then transform the information into blood pressure values. With Biospectal’s software solutions, anyone in the world with a smartphone can turn their device into a connected, smart, clinical-grade monitor in the time it takes to download and install an app. Key benefits include:

  • Connected remote monitoring shortens pathways from measurement to action in a clinical regimen
  • Ease of use with an existing ubiquitous device — the smartphone — removes adherence barriers
  • App form factor offers continuous product improvement and feature update
  • Unprecedented data insights via worldwide device network drive high value for drug development and lower insurance costs

According to the World Health Organization, an estimated 1.13 billion people worldwide have hypertension, and only one in five people have control over the condition. Equally, the onset of COVID-19 has exacerbated people’s ability to monitor and manage their blood pressure accurately. People need a digital means to monitor, track and share blood pressure data with their doctors.

Backed by grants from Grand Challenges Canada and the Bill & Melinda Gates Foundation, Biospectal’s OptiBP smartphone app and connected data platform enables clinical-grade blood pressure management at the ‘point of patient’ without the need for bulky extra hardware. OptiBP provides better ‘cuffless’ tracking of blood pressure, and the data captured can connect seamlessly with a user’s doctor to support a treatment regimen to help improve health, longevity and quality of life.

“We view OptiBP as a clear case of disruption of an old paradigm of the blood pressure cuff. We are passionate and grateful to have developed this novel approach to blood pressure measurement to democratize access to healthcare monitoring and improve lives at a global scale,” added Eliott Jones, CEO of Biospectal.

Access the Biospectal Press Kit here. For more information, please visit https://www.biospectal.com.

About Biospectal

Biospectal is the remote monitoring and biosensing software company focused on the worldwide democratization of clinical monitoring. We make it easy for hypertension patients and health-conscious consumers to take on hypertension – aka the ‘silent killer’ and #1 chronic health condition worldwide. Biospectal’s OptiBP™ smartphone application and data platform remove the outdated blood pressure cuff barrier and enables frequent and intelligent blood pressure tracking via a fingertip applied to a smartphone camera lens. By optically measuring blood flow through the skin, our proprietary algorithm turns light information into blood pressure values. Now, anyone with a smartphone can have the convenience of a connected blood pressure monitor with them anytime, anywhere.

Founded in July 2017, Biospectal is headquartered in Lausanne, Switzerland, with an additional office in Silicon Valley. Biospectal’s patented technology was co-developed and clinically validated by the Swiss Center for Electronics and Microtechnology and represents 10+ years of non-invasive optical biosensing R&D. Read our news, like us on Facebook, follow us on Twitter, or learn more at https://biospectal.com.

###

Share article on social media or email:



Atlantic County Justice Facility named R. Scott Chavez Facility of the Year


The NCCHC award honors ACJF’s joint partnership with JBRC.

“JBRC and the ACJF implemented the state’s first program to provide medication-assisted treatment to inmates,” said Michael Santillo, CEO of John Brooks Recovery Center.

Many people in the recovery community feel strongly that medication-assisted treatment is the key to sobriety and removing barriers is the first step in long-term recovery. Leading the charge is John Brooks Recovery Center (JBRC) in partnership with the Atlantic County Justice Facility (ACJF) as they strive to break the cycle of crime and addiction.

The tireless efforts of these two organizations have been commended as the National Commission on Correctional Health Care (NCCHC) recently named the ACJF as the R. Scott Chavez Facility of the Year. This prestigious award honors one facility among several hundred accredited by the commission for its outstanding quality, innovation and dedication.

The NCCHC highlighted the ACJF’s joint partnership with JBRC, which provides onsite medication-assisted treatment, along with counseling and connections to continued treatment upon release for addicted inmates. “JBRC and the ACJF implemented the state’s first program to provide medication-assisted treatment to inmates,” said Michael Santillo, CEO of John Brooks Recovery Center. “This program provides medications that effectively manage the symptoms of drug withdrawal, reduce the risk of relapse and overdose and provides individual and group counseling for those suffering with substance use disorders.”

When health staff, custody staff and leadership work together to provide their best, along with numerous community partners, the results go above and beyond the requirements of the NCCHC jail standards. That is what NCCHC surveyors found to be true at the ACJF in Mays Landing.

The award highlights the ACJF’s impact on mental health, suicide prevention and access by all inmates to medical and mental health providers. “Through community partnerships, the facility provides on-site medication-assisted treatment, along with counseling and linkage to continued treatment upon release, and a comprehensive reentry program provides assistance with housing, health insurance and case management,” according to the NCCHC.

The ACJF was the first to provide a model for a $1.7M New Jersey pilot program to bring medication-assisted treatment to multiple counties throughout the state, according to Santillo. “Last year, we were honored to have state Commissioner of Human Services Carole Johnson come to our Pleasantville facility to announce $8M in funding to provide such treatment at all county jails,” he added.

Medication-assisted treatment is a long-term approach to recovery requiring daily participation for medication with weekly counseling. As the individual stabilizes and makes progress toward recovery goals, the frequency/attendance decreases based on clinical/medical staff assessments.

All Roads Recovery (the community-based recovery arm of JBRC) also works in conjunction with Atlantic County jails post-incarceration. “All Roads Recovery follows individuals out of the jail in order to help them navigate their next steps on the journey to recovery,” Santillo added. “The most important part of the discharge plan is to link individuals to services once they leave the jail. All Roads Recovery does just this and has become a refuge for returning citizens.”

Looking to the future, JBRC will continue to partner with ACJF to help inmates pursue recovery. “Medication-assisted treatment works,” said Santillo. “And we will do our best to save as many lives as possible.”

About John Brooks Recovery Center

Founded in 1969, John Brooks Recovery Center provides quality, individualized treatment services to help individuals overcome substance use disorders. Programs include: Residential, Outpatient, Medication-assisted Recovery and Inmate Re-entry. To learn more, visit jbrcnj.org or visit them on Facebook @JohnBrooksRecoveryCenter.

About All Roads Recovery Community Center

All Roads Recovery Community Center, the community-based recovery arm of JBRC, helps anyone struggling with addiction navigate their next steps on the journey to recovery. All Roads currently offers a wide variety of Recovery Groups, as well as one-on-one coaching with Certified Peer Recovery Specialists (CPRS). To learn more, visit allroadsrecovery.org, call 609-457-1080 or visit them on Facebook @AllRoadsRCC.

https://jbrcnj.org/about-us/blog-newsroom/entry/2020/12/22/atlantic-county-justice-facility-named-r-scott-chavez-facility-of-the-year.html

Share article on social media or email:

Senator Darryl Rouson Delivers Donated Oculus 2 VR Headsets, Tablets, and UVC Test Cards to All Children’s Hospital


Jason Labossiere reached out to Senator Darryl Rouson to ensure terminally ill children at all children's hospital have something to smile about this Christmas

Jason Labossiere reached out to Senator Darryl Rouson to ensure terminally ill children at all children’s hospital have something to smile about this Christmas

Senator Rouson added, “I am proud that children in healing at a world-class medical institution in Senate District 19 will benefit from this incredible gift.”

– WarOnFlu Donates Sold-out Oculus Quest 2 VR Headsets With Tablets To All Children’s Hospital

  • QuantaDose Donates 200 QuantaDose UVC test cards for WarOnFlu (WOF) COVID Survivor Packages
  • Senator Darryl Rouson Makes Special Delivery Possible To Children’s Hospital With Christmas Stash Of Oculus Quest 2 VR Headsets With Tablets

The War on Flu Inc., a not-for-profit 501(c)(3), has made it their mission to help- children fighting for their life see the world in a whole new way this Christmas. COVID-19 has taken away resources to the non-profit world and overshadowed the many other current societal needs, including children with chronic or terminal medical conditions. With the end of the year 2020 insight and Christmas on the horizon, this new non-profit, along with its directors and co-founders Jason LaBossiere, Kristina Boatman, and Mel Sams, are bringing an incredible gift to John Hopkins All Children’s Hospital by donating fifty Oculus 2 virtual reality (VR) headsets and fifty tablets. Oculus headsets allow the user to be fully immersed in virtual reality, whether flying and exploring new lands or playing a game against others near or far.

At Stanford School of Medicine, doctors have found that virtual reality systems help children escape pain and anxiety by distracting their brains in this fully immersive reality. One study by the University of Washington found burn victims felt 50% less pain when being treated while experiencing virtual reality.

The War on Flu founder Jason LaBossiere has coordinated the donation with newly reelected Florida Senator Darryl Rouson. Mr. LaBossiere commented, “This is only the start of our giving. These kids need everyone’s help. The pandemic has overshadowed many things; it won’t be the kids at All Children’s hospital this holiday season. We really want a smile on these children’s faces on Christmas Day. However, our main goal is to help these kids reduce anxiety, stress, and pain while enduring regimental medical treatments while just having fun exploring this new immersive VR technology.”

Senator Darryl Rouson (D). District 19. and Jason Labossiere were presented with a certificate of appreciation from Johns Hopkins All Children’s Hospital.

Senator Rouson added, “I am proud that children in healing at a world-class medical institution in Senate District 19 will benefit from this incredible gift.”

The donation to Johns Hopkins All Children’s Hospital, formerly All Children’s Hospital, located in St. Petersburg, Florida, comes with stocking stuffers for the pediatric patients’ parents and guardians.

The War on Flu included a donation of 200 QuantaDose UVC light test cards to give away to the parents and family members visiting their love-ones at All Children’s Hospital.

According to Mr. LaBossiere, “There are a lot of fake UV disinfection products being sold openly by third-party sellers on mainstream online marketplaces. Fake UV light products marketed with unverified claims, available 24/7 to our neighbors, are a potentially fatal scam during the pandemic. The QuantaDose UVC light test card can instantly identify a fake UVC light, so people are not relying on a false sense of virus cleaning before entering All Children’s Hospital.”

Florida-based Gym, WeBeFit, posted a youtube video using a QuantaDose card identifying fake UV lights before using them to protect everyone in their surrounding community.

LaBossiere said, “One fake UVC light in the wrong place at the wrong time can endanger lives in an entire community. The Oculus 2 VR headsets are a great gift for the kids at All Children’s Hospital, and the QuantaDose UVC test cards are a must for those depending on authentic UVC light devices purchased online to aid in the disinfection process.”

This donation was made possible with the help of:

Senator Darryl Ervin Rouson (D), District 19, St. Petersburg, Florida

Katie Webb & John Coates, Quanta X Technology LLC, Seminole, FL

Kristina Boatman, Odyssey Yoga LLC, Saint Petersburg, FL

Citgo J & L Stop and Shop, Redington Beach FL

To support The War On Flu’s latest project, COVID Survivor Packages, for connecting survivors with local businesses offering special discounts for unity in our local recovery and healing process, please visit http://www.waronflu.org.

Share article on social media or email:

AseptiScope, Inc.™ President and CEO, Scott Mader, Featured in CEOCFO Magazine


In November we announced the introduction of The DiskCover System in the United States. Now, just a few weeks into our commercial availability, we are seeing our System adopted increasingly in institutions across the country

AseptiScope, Inc.™, a privately funded San Diego, California-based clinical innovation company, announced that Scott Mader, company President and CEO, is featured in the latest issue of CEOCFO Magazine. In a wide-ranging interview, Mr. Mader discusses the founding and financing of the company, the development, manufacturing, and commercialization of its flagship stethoscope hygiene product, The DiskCover™ System, and the company’s plans for expansion in the infection control landscape at home and abroad.

“Our mission is to elevate infection protection for both clinician and patient through market-driven innovation,” said Mr. Mader. “Despite the increased vigilance of infection control, healthcare acquired infections remain a daunting challenge. The gaps in our infection control protocols and practices, including the absence of practical and effective stethoscope hygiene options, undermine these efforts,” Mader added.

The DiskCover System (https://www.diskcover.com) is the first and only touch-free stethoscope barrier dispensing system. The System dispenses single-use aseptic disk covers that are proven to protect patients from exposure to harmful pathogens and contaminants on the stethoscope diaphragm without compromising the acoustics critical for accurate diagnoses. The compact DiskCover Dispenser, designed to be mounted in or near hand hygiene stations in the clinical setting, applies individual disk covers instantly, minimizing workflow disruption while encouraging clinician compliance. The DiskCover Dispenser is uniquely designed to ensure each stethoscope exam is always aseptic, and is the first workflow compatible option, optimizing compliance.

“In November we announced the introduction of The DiskCover System in the United States. Now, just a few weeks into our commercial availability, we are seeing our System adopted increasingly in institutions across the country,” Mr. Mader stated. “We look forward now to an exciting 2021, a year in which we will see continued commercial growth for The DiskCover System in the US, our first international commercialization effort, and the unveiling of our next infection control innovation,” Mader concluded.

Read the full article: https://ceocfointerviews.com/aseptiscope20.html

About CEOCFO Magazine

CEOCFO Magazine, is an independent business news and investment publication that highlights important technology, products, services, medical, natural health clean-tech and financial companies. Publishing since September 1999, CEOCFO brings interviews with CEOs and other top executives in their own words and thoughts to our worldwide readership. In a CEOCFO interview you will find salient insights into product discovery, development, go to market strategy, customer and partnership acquisition and retention.

About AseptiScope, Inc.

AseptiScope, formed in early 2016, is a privately funded San Diego, California based, clinical innovation company. The company is founded and led by clinical innovation experts, leading medical researchers and practicing physicians. The AseptiScope mission is to design, develop, manufacture and commercialize novel solutions that offer “Infection Protection for Clinician & Patient.” The company has now launched the first true and practical solution for the longstanding challenge of stethoscope contamination: The DiskCover System. Visit https://www.diskcover.com for more information or https://store.aseptiscope.com to purchase directly.

AseptiScope, DiskCover and related logos are trademarks of AseptiScope, Inc.

Share article on social media or email:

Fenway Health, other Organizations Call for LGBTQI Data Collection & Targeted Outreach in COVID-19 Vaccine Distribution Efforts


Because they are more likely to hold front line jobs and have certain chronic conditions, LGBTQI people may be disproportionately vulnerable to novel coronavirus infection and to complications should they develop COVID-19.

Today, over 125 organizations called upon the Association of State and Territorial Health Officers to create an inclusive and coordinated plan to distribute the COVID-19 vaccine and to make concerted efforts to reach and establish trust with LGBTQI populations. Read the letter here.

Within the United States, Black, Indigenous, Latinx, and other communities of color have borne the brunt of the illness and death resulting from the pandemic. It is imperative that the COVID-19 vaccination efforts reach those communities. In addition, LGBTQI people must be included in comprehensive and targeted messaging campaigns in order for these populations to participate in vaccination efforts.

“Black, Indigenous, Latinx, and communities of color, LGBTQ communities – and those at the intersections of these communities – face consistent barriers to accessing affirming health care. With COVID-19’s widespread impact, including lives lost, and increasing barriers to care like reduced hospital capacity, loss of benefits and cancellation of non-urgent care, it is more imperative than ever that our healthcare leaders at the state, local and national level work to better engage these communities in the healthcare system and prevent further harms to these communities,” said Juan Carlos Loubriel, Director of Community Health and Wellness at Whitman-Walker Health.

“Better engaging communities looks like providing affirming healthcare environments and understanding the full picture of the patient in front us by collecting more thorough data – and asking the right questions to collect that data. We must document gender identity and sexual orientation in addition to data points like race and ethnicity to ensure that COVID-19 vaccine distribution efforts reach all communities represented in our complete population.”    

Public health initiatives to reach communities who may have significant and understandable mistrust of the medical establishment must motivate these constituents to receive the vaccine. This will mean explicitly naming and incorporating the recommendations of leaders within LGBTQI communities, as well as those of BIPOC, disability rights and leaders of other underserved populations.

“Community influencers are on social media asking why they should trust a vaccine made by a government that has not supported us. It’s a valid question. We need state health leadership to acknowledge this vaccination hesitancy and help us counter this narrative before our communities’ health disparities get even worse,” says Dr. Scout, the Executive Director of the National LGBT Cancer Network.

Additionally, these organizations called upon Association of State and Territorial Health Officers to include the collection of sexual orientation, gender identity, and intersex status data in their vaccine dissemination plan for LGBTQI communities in order to track and respond to issues for these communities. Citing that vaccine information to LGBTQI communities should come from a range of trusted sources, the letter also makes the case that collecting SOGI data will allow local governments and health officials to better support these communities, and more thoroughly respond to public health crises, in the future.

“Because they are more likely to hold front line jobs and have certain chronic conditions, LGBTQI people may be disproportionately vulnerable to novel coronavirus infection and to complications should they develop COVID-19. This is especially true of Black, Latinx and indigenous LGBTQI people and LGBTQI older adults,” said Sean Cahill, Director of Health Policy Research at The Fenway Institute. “Due to negative experiences in the health care system and high rates of medical mistrust, many LGBTQI people may be reluctant to access the vaccine when it becomes available.”

Share article on social media or email:

Medical Breakthrough as KICVentures Group Closes Its Land-Mark Acquisition of NanoFUSE Biologics


NanoFUSE Biologics is a combination of patented bioactive glass plus demineralized bone matrix (DBM)

NanoFUSE Biologics is a world leader in synthetic biologics and is the only FDA-cleared combination of demineralized bone matrix (DBM) and bioactive glass indicated in orthopedic surgery.

KICVentures Group announces a medical breakthrough in closing the acquisition and bringing to market NanoFUSE Biologics, the first and only FDA-cleared synthetic combination of a patented bioactive glass plus demineralized bone matrix (DBM).

KICVentures Group is excited to announce it has closed the NanoFUSE Biologics acquisition with the final milestone payment made in September 2020. The acquisition was entered in March 2018 and structured as a five-year deal with milestones.

With the increasing interest of NanoFUSE products and fast-growing adoption, we are pleased to complete the acquisition within three years by accelerating milestone payments. Since the acquisition in 2018, we have established the manufacturing process, engaged distribution partners, focused on quality and secured a pipeline of product innovation, along with an esteemed medical advisory board.

Aditya Humad, CFO of KICVentures Group stated that: “With an accelerated closure of this acquisition, we are positioned to independently negotiate strategic partnerships and prepare the company for an IPO in 3 years.”

Dr. Kingsley R. Chin, CEO of KICVentures Group and board-certified orthopedic spine surgeon said, “This acquisition was a medical breakthrough in that we are able to bring this differentiated product, the sole one in its category with FDA clearance, to a crowded global biologics market. The 5-year shelf life is a powerful advantage in the international market.”

About NanoFUSE Biologics

NanoFUSE Biologics is a world leader in synthetic biologics. NanoFUSE is the only FDA-cleared combination of DBM and bioactive glass and is indicated for use in orthopedic surgery. NanoFUSE Biologics is a KICVentures group portfolio company. http://www.nanofusebiologics.com

About KICVentures Group

KICVentures Group is a privately held global corporation who since 2005 has been leading waves of change with differentiated health technologies with a deep focus on outpatient less invasive spine surgery. The company has headquarters in Boston, USA. http://www.kicventuresgroup.com

Share article on social media or email:

Increased Meat Consumption Associated With Symptoms of Childhood Asthma, Mount Sinai Study Suggests


Substances present in cooked meats are associated with increased wheezing in children, Mount Sinai researchers report. Their study, published in Thorax, highlights pro-inflammatory compounds called advanced glycation end-products (AGEs) as an example of early dietary risk factors that may have broad clinical and public health implications for the prevention of inflammatory airway disease.

Asthma prevalence among children in the United States has risen over the last few decades. Researchers found that dietary habits established earlier in life may be associated with wheezing and potentially the future development of asthma.

Researchers examined 4,388 children between 2 and 17 years old from the 2003-2006 National Health and Nutrition Examination Survey (NHANES), a program of the National Center for Health Statistics, which is part of the U.S. Centers for Disease Control and Prevention. It is designed to evaluate the health and nutritional status of adults and children in the United States through interviews and physical examinations.

The researchers used NHANES survey data to evaluate associations between dietary AGE and meat consumption frequencies, and respiratory symptoms. They found that higher AGE intake was significantly associated with increased odds of wheezing, importantly including wheezing that disrupted sleep and exercise, and that required prescription medication. Similarly, higher intake of non-seafood meats was associated with wheeze-disrupted sleep and wheezing that required prescription medication.

“We found that higher consumption of dietary AGEs, which are largely derived from intake of non-seafood meats, was associated with increased risk of wheezing in children, regardless of overall diet quality or an established diagnosis of asthma,” said Jing Gennie Wang, MD, lead author of the study, and a former fellow in Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine at Mount Sinai.

“Research identifying dietary factors that influence respiratory symptoms in children is important, as these risks are potentially modifiable and can help guide health recommendations. Our findings will hopefully inform future longitudinal studies to further investigate whether these specific dietary components play a role in childhood airways disease such as asthma,” said Sonali Bose, MD, senior author, and Assistant Professor of Pulmonary, Critical Care and Sleep Medicine and Pediatrics at Icahn School of Medicine at Mount Sinai.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email: